According to Fortune Business Insights, the U.S. veterinary diagnostics market size was worth USD 3.39 billion in 2023 and is projected to grow at a CAGR of 8.6% during the forecast period.
The market is gaining importance as veterinary healthcare providers increasingly rely on diagnostic technologies to identify animal diseases, monitor health conditions, and support treatment decisions. Veterinary diagnostics includes a range of laboratory tests, diagnostic instruments, reagents, and services used to detect infectious diseases, metabolic disorders, parasitic infections, and other health conditions in companion and livestock animals. Growing pet ownership, rising awareness of animal health, and increasing expenditure on veterinary care are supporting market development. The U.S. veterinary diagnostics market is also benefiting from advances in diagnostic technologies that enable faster testing, improved accuracy, and more efficient clinical decision-making. Veterinary hospitals, diagnostic laboratories, research institutions, and animal healthcare facilities are increasingly adopting modern testing solutions to improve disease detection and animal care.
Continue reading for more details:
https://www.fortunebusinessinsights.com/u-s-veterinary-diagnostics-market-107887
The U.S. veterinary diagnostics market can be segmented by product, technology, animal type, application, and end user. Product-based segmentation includes instruments, consumables, reagents, and diagnostic services. Instruments are used to conduct laboratory analyses and point-of-care testing, while consumables and reagents are essential for performing diagnostic procedures. Diagnostic services support veterinary professionals by providing laboratory testing, interpretation, and specialized analysis for different animal health conditions. Continued innovation in testing equipment and laboratory solutions is encouraging the adoption of diagnostic products across veterinary care settings.
By technology, the market includes immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other diagnostic methods. Immunodiagnostic tests help identify specific antigens or antibodies associated with diseases and immune responses. Clinical biochemistry supports the evaluation of organ function and metabolic conditions, while hematology enables the assessment of blood components. Molecular diagnostics, including polymerase chain reaction-based testing, can detect genetic material associated with infectious agents and other conditions. These technologies help veterinary professionals select appropriate tests based on clinical symptoms, suspected diseases, and the required diagnostic accuracy.
Based on animal type, the U.S. veterinary diagnostics market covers companion animals and livestock animals. Companion animals, including dogs and cats, represent an important segment because pet owners increasingly seek preventive healthcare, routine examinations, and timely diagnosis of illnesses. Livestock diagnostics supports the identification and management of diseases affecting animals raised for food production and other agricultural purposes. Effective disease monitoring helps veterinarians and livestock producers protect animal welfare, maintain herd health, and reduce the potential spread of infections.
By application, the market includes infectious diseases, parasitic diseases, orthopedic and musculoskeletal conditions, cardiology, oncology, and other health concerns. Infectious disease testing is important for identifying pathogens and supporting appropriate treatment decisions. Diagnostic testing also assists in monitoring chronic conditions and evaluating organ function. By end user, the market serves veterinary hospitals and clinics, diagnostic laboratories, research institutions, and other animal healthcare facilities. The adoption of diagnostic solutions depends on clinical requirements, testing capacity, equipment availability, and the need for reliable results.